Literature DB >> 23982630

Willingness to pay and quality of life in patients with atopic dermatitis.

F C Beikert1, A K Langenbruch, M A Radtke, T Kornek, S Purwins, M Augustin.   

Abstract

Atopic dermatitis (AD) is a frequent and burdensome disease. The objectives of this study were (1) to assess the willingness to pay (WTP) and quality of life (Qol) in AD patients and (2) to compare the results with data on other chronic skin diseases. To collect data, a non-interventional, cross-sectional nationwide postal survey on adult patients with clinically diagnosed AD was performed; socio-demographic data, clinical features/symptoms, WTP and QoL were recorded. WTP was assessed in three different approaches, including relative and absolute figures. Data from n = 384 AD patients (mean age 42.0, range 18-92, 69.8 % female) were analyzed. WTP for complete healing was on median <euro>1,000 (average <euro>11,884) and exceeded WTP in rosacea (median <euro>500) but not in vitiligo (median <euro>3,000). Mean Dermatology Life Quality Index (DLQI) was 8.5 (vitiligo 7.0; psoriasis 6.7; rosacea 4.3) and correlated with pruritus, xerosis and disturbed sleep. WTP and DLQI correlated only marginally (r s = 0.134, p = 0.01). In conclusion, AD patients show high WTP and markedly reduced QoL compared to other chronic skin diseases.

Entities:  

Mesh:

Year:  2013        PMID: 23982630     DOI: 10.1007/s00403-013-1402-1

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  22 in total

Review 1.  The role of the skin microbiome in atopic dermatitis.

Authors:  Michael R Williams; Richard L Gallo
Journal:  Curr Allergy Asthma Rep       Date:  2015-11       Impact factor: 4.806

Review 2.  Selected comorbidities of atopic dermatitis: Atopy, neuropsychiatric, and musculoskeletal disorders.

Authors:  Jonathan I Silverberg
Journal:  Clin Dermatol       Date:  2017-03-24       Impact factor: 3.541

3.  [Patient education for adults with atopic dermatitis according to the ARNE concept].

Authors:  A Heratizadeh; T Werfel; U Gieler; J Kupfer
Journal:  Hautarzt       Date:  2018-03       Impact factor: 0.751

4.  The costs of celiac disease: a contingent valuation in Switzerland.

Authors:  Laia Soler; Nicolas Borzykowski
Journal:  Eur J Health Econ       Date:  2021-10-07

5.  Association between childhood eczema and headaches: An analysis of 19 US population-based studies.

Authors:  Jonathan I Silverberg
Journal:  J Allergy Clin Immunol       Date:  2015-08-29       Impact factor: 10.793

6.  Willingness to Pay and QOL in Alopecia Areata.

Authors:  Jean-Phillip Okhovat; Tristan Grogan; Lewei Duan; Carolyn Goh
Journal:  J Investig Dermatol Symp Proc       Date:  2020-11

Review 7.  S2k guideline on diagnosis and treatment of atopic dermatitis - short version.

Authors:  Thomas Werfel; Annice Heratizadeh; Werner Aberer; Frank Ahrens; Matthias Augustin; Tilo Biedermann; Thomas Diepgen; Regina Fölster-Holst; Uwe Gieler; Julia Kahle; Alexander Kapp; Alexander Nast; Katja Nemat; Hagen Ott; Bernhard Przybilla; Martin Roecken; Martin Schlaeger; Peter Schmid-Grendelmeier; Jochen Schmitt; Thomas Schwennesen; Doris Staab; Margitta Worm
Journal:  Allergo J Int       Date:  2016-05-02

Review 8.  Frequency and Management of Sleep Disturbance in Adults with Atopic Dermatitis: A Systematic Review.

Authors:  Caleb Jeon; Di Yan; Mio Nakamura; Sahil Sekhon; Tina Bhutani; Timothy Berger; Wilson Liao
Journal:  Dermatol Ther (Heidelb)       Date:  2017-07-13

Review 9.  Comprehensive Approach: Current Status on Patient Education in Atopic Dermatitis and Other Allergic Diseases.

Authors:  Stephan Traidl; Claudia Lang; Peter Schmid-Grendelmeier; Thomas Werfel; Annice Heratizadeh
Journal:  Handb Exp Pharmacol       Date:  2022

10.  Prevalence and Risk Factors of Anxiety and Depression in Rosacea Patients: A Cross-Sectional Study in China.

Authors:  Mengting Chen; Zhili Deng; Yingxue Huang; Ji Li
Journal:  Front Psychiatry       Date:  2021-06-16       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.